May 12, 2017 / 10:39 AM / 6 months ago

BRIEF-Ardelyx reports successful phase 3 t3mpo-1 trial of tenapanor

May 12 (Reuters) - Ardelyx Inc:

* Ardelyx reports successful phase 3 t3mpo-1 trial of tenapanor in patients with IBS-C

* Ardelyx reports successful phase 3 t3mpo-1 trial of tenapanor in patients with IBS-C

* Ardelyx Inc - study achieves primary endpoint

* Ardelyx Inc - tenapanor was well-tolerated, consistent with experience across previous clinical trials

* Says it plans to assess the data alongside results from t3mpo-2, co’s six-month phase 3 study Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below